SEC Form 4 research
| Issuer | IMMUNIC, INC. |
|---|---|
| Tickers | IMUX, VTL |
| Reporting owners | 61 |
| Officers and directors | 16 |
| Last public filing | 2026-09-19 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-18 | 2026-09-16 | Nagel Robert Thorvald | A | 25,370 | $0 | Not reported |
| 2026-09-18 | 2026-09-16 | BIOTECHNOLOGY VALUE FUND II LP, BIOTECHNOLOGY VALUE FUND L P, BVF GP HOLDINGS LLC, BVF I GP LLC, BVF II GP LLC, BVF INC/IL, BVF PARTNERS L P/IL, BVF Partners OS Ltd., Biotechnology Value Trading Fund OS LP, LAMPERT MARK N | A | 25,370 | $0 | Not reported |
| 2026-08-10 | 2026-08-06 | Ridloff Elena | A | 50,740 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.